JohnH.HalpernMD

PubMed

• 42 citations
  The association of psychedelic use and opioid use disorders among illicit users in the United States
  Vincent D. Pisano, Nathaniel P Putnam, Hannah M Kramer, Kevin Franciotti, John H. Halpern, Selma C. Holden> ;Journal of Psychopharmacology. 2017 Feb 14
• 50 citations
  A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.
  John H. Halpern, Arturo G. Lerner, Torsten Passie> ;Current Topics in Behavioral Neurosciences. 2016 Jan 1
• 5 citations
  Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting.
  Vicka Rael Corey, Vincent D. Pisano, John H. Halpern> ;The Journal of Nervous and Mental Disease. 2016 Jul 1
• 3 citations
  Reply to: 'illicit drugs and cluster headache: an inevitable discussion'.
  John H. Halpern> ;Cephalalgia. 2013 Mar 8
• 80 citations
  Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
  Torsten Passie, Hinderk M. Emrich, Matthias Karst, Simon D. Brandt, John H. Halpern> ;Drug Testing and Analysis. 2012 Jul 1
• The right medicine for World Drug Day.
  John H. Halpern> ;The Indian Journal of Medical Research. 2012 Jun 1
• 29 citations
  Genuine and drug-induced synesthesia: a comparison.
  Christopher Sinke, John H. Halpern, Markus Zedler, Janina Neufeld, Hinderk M. Emrich, Torsten Passie> ;Consciousness and Cognition. 2012 Sep 1
• 55 citations
  Residual neurocognitive features of long‐term ecstasy users with minimal exposure to other drugs.
  John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci A. Gruber, David Kozin, Harrison G. Pope> ;Addiction. 2011 Apr 1
• 58 citations
  The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.
  Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie> ;Cephalalgia. 2010 Mar 26
• 232 citations
  The pharmacology of lysergic acid diethylamide: a review.
  Torsten Passie, John H. Halpern, Dirk O. Stichtenoth, Hinderk M. Emrich, Annelie Hintzen> ;CNS Neuroscience & Therapeutics. 2008 Dec 1
• 6 citations
  "Enhanced" interrogation of detainees: do psychologists and psychiatrists participate?
  Abraham L. Halpern, John H. Halpern, Sean B Doherty> ;Philosophy, Ethics, and Humanities in Medicine. 2008 Sep 25
• 74 citations
  Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.
  John H. Halpern, Andrea R. Sherwood, Torsten Passie, Kimberly C Blackwell, A James Ruttenber> ;Medical Science Monitor. 2008 Aug 1
• 231 citations
  Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).
  Edward W. Boyer, Kavita M. Babu, Jessica E. Adkins, Christopher R. McCurdy, John H. Halpern> ;Addiction. 2008 Jun 1
• 134 citations
  Response of cluster headache to psilocybin and LSD.
  R. Andrew Sewell, John H. Halpern, Harrison G. Pope> ;Neurology. 2006 Jun 27
• 14 citations
  Hallucinogenic botanicals of America : A growing need for focused drug education and research
  John H. Halpern, R. Andrew Sewell> ;Life Sciences. 2005 Dec 22
• 74 citations
  Psychological and cognitive effects of long-term peyote use among Native Americans.
  John H. Halpern, Andrea R. Sherwood, James I. Hudson, Deborah A. Yurgelun-Todd, Harrison G. Pope> ;Biological Psychiatry. 2005 Oct 15
• 99 citations
  Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
  John H. Halpern, Harrison G. Pope, Andrea R. Sherwood, Steven Barry, James I. Hudson, Deborah A. Yurgelun-Todd> ;Drug and Alcohol Dependence. 2004 Aug 16
• 6 citations
  Now is the time for AAPL to demonstrate leadership by advocating positions of social importance.
  Abraham L. Halpern, John H. Halpern, Alfred M. Freedman> ;The Journal of the American Academy of Psychiatry and the Law. 2004 Jun 1
• 112 citations
  Hallucinogens and dissociative agents naturally growing in the United States.
  John H. Halpern> ;Pharmacology & Therapeutics. 2004 May 1
• 27 citations
  Hallucinogens: an update.
  John H. Halpern> ;Current Psychiatry Reports. 2003 Oct 1
• 31 citations
  Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration.
  John H. Halpern, Michelle B. Sholar, Julie Glowacki, Nancy K. Mello, Jack H. Mendelson, Arthur J. Siegel> ;The Journal of Clinical Endocrinology and Metabolism. 2003 Mar 1
• 95 citations
  Hallucinogen persisting perception disorder: what do we know after 50 years?
  John H. Halpern, Harrison G. Pope> ;Drug and Alcohol Dependence. 2003 Mar 1
• 49 citations
  Temporal concordance of cocaine effects on mood states and neuroendocrine hormones
  Jack H. Mendelson, Nancy K. Mello, Michelle B. Sholar, Arthur J. Siegel, Nicole H. Mutschler, John H. Halpern> ;Psychoneuroendocrinology. 2002 Jan 1
• 63 citations
  Hallucinogens on the Internet: A Vast New Source of Underground Drug Information
  John H. Halpern, Harrison G. Pope> ;The American Journal of Psychiatry. 2001 Mar 1
• 41 citations
  Do hallucinogens cause residual neuropsychological toxicity
  John H. Halpern, Harrison G. Pope> ;Drug and Alcohol Dependence. 1999 Feb 1
• Join now to see all